Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01255748

Registry Study for Radiation Therapy Outcomes

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic, Scottsdale, Arizona, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent

Treatment and study plan

Proton Therapy, Photon Therapy, SRS, Brachytherapy

Radiation

Outcomes Tracking

Primary outcomes

  1. Define outcomes for patients treated at participating institutions

    Time frame: PRN

Secondary outcomes

  1. Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures

    Time frame: Annually PRN

  2. Improve patient care by an adequate understanding of the results and patient population at participating institutions

    Time frame: Reviewed Annually PRN

Sponsors and collaborators

Lead sponsor

Proton Collaborative Group

Network

Registry information

Official study title

Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy

Important dates

Study start
2009
Primary completion
2039
First posted
Dec 7, 2010
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.